Strychnine
Strychnine is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M4, glycine receptor subunit alpha-1, muscarinic acetylcholine receptor M5, muscarinic acetylcholine receptor M3, neuronal acetylcholine receptor subunit alpha-9, glycine receptor subunit alpha-2, neuronal acetylcholine receptor subunit alpha-10, glycine receptor subunit alpha-3, and muscarinic acetylcholine receptor M1.
Download report
Favorite
Searched
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | STRYCHNINE |
INN | — |
Description | Strychnine is a monoterpenoid indole alkaloid that is strychnidine bearing a keto substituent at the 10-position. It has a role as an avicide, a glycine receptor antagonist, a cholinergic antagonist, a rodenticide and a neurotransmitter agent. It is a monoterpenoid indole alkaloid and an organic heteroheptacyclic compound. It is a conjugate base of a strychnine(1+). It derives from a hydride of a strychnidine. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46 |
Identifiers
PDB | 5OBG |
CAS-ID | 57-24-9 |
RxCUI | 66422 |
ChEMBL ID | CHEMBL227934 |
ChEBI ID | 28973 |
PubChem CID | 441071 |
DrugBank | DB15954 |
UNII ID | — |
Target
Agency Approved
No data
Alternate
CHRM2
CHRM2
CHRM4
CHRM4
GLRA1
GLRA1
CHRM5
CHRM5
CHRM3
CHRM3
CHRNA9
CHRNA9
GLRA2
GLRA2
CHRNA10
CHRNA10
GLRA3
GLRA3
CHRM1
CHRM1
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 14,566 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
21,783 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more